As the government’s oldest consumer protection agency, the FDA has long butted up against drugmakers, activists and politicians. But undermining its work could be harmful to patient health and safety.
Mifepristone’s safety in medication abortions has been well established over more than two decades, but legal wrangling leaves the future of the drug hanging in the balance.
The US Supreme Court on Friday temporarily preserved full access to a widely-used abortion pill, putting on hold lower court decisions placing restrictions on the drug.